Follow
Steven Shechter
Steven Shechter
Professor, Sauder School of Business, University of British Columbia
Verified email at sauder.ubc.ca
Title
Cited by
Cited by
Year
Modeling medical treatment using Markov decision processes
AJ Schaefer, MD Bailey, SM Shechter, MS Roberts
Operations research and health care: A handbook of methods and applications …, 2004
2442004
The optimal time to initiate HIV therapy under ordered health states
SM Shechter, MD Bailey, AJ Schaefer, MS Roberts
Operations Research 56 (1), 20-33, 2008
2092008
Estimating the impact of alcohol consumption on survival for HIV+ individuals
RS Braithwaite, J Conigliaro, MS Roberts, S Shechter, A Schaefer, ...
AIDS care 19 (4), 459-466, 2007
1582007
A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process
SM Shechter, CL Bryce, O Alagoz, JE Kreke, JE Stahl, AJ Schaefer, ...
Medical Decision Making 25 (2), 199-209, 2005
1472005
Prospect theory and the newsvendor problem
M Nagarajan, S Shechter
Management Science 60 (4), 1057-1062, 2014
1302014
The use of discrete-event simulation modelling to improve radiation therapy planning processes
G Werker, A Sauré, J French, S Shechter
Radiotherapy and Oncology 92 (1), 76-82, 2009
1082009
A methodological framework for optimally reorganizing liver transplant regions
JE Stahl, N Kong, SM Shechter, AJ Schaefer, MS Roberts
Medical Decision Making 25 (1), 35-46, 2005
912005
Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model
RS Braithwaite, MS Roberts, CCH Chang, MB Goetz, CL Gibert, ...
Annals of internal medicine 148 (3), 178-185, 2008
882008
Timing of arteriovenous fistula creation in patients with CKD: a decision analysis
SM Shechter, MR Skandari, N Zalunardo
American journal of kidney diseases 63 (1), 95-103, 2014
712014
Incorporating biological natural history in simulation models: empirical estimates of the progression of end-stage liver disease
O Alagoz, CL Bryce, S Shechter, A Schaefer, CCH Chang, DC Angus, ...
Medical Decision Making 25 (6), 620-632, 2005
682005
Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation
RS Braithwaite, S Shechter, MS Roberts, A Schaefer, DR Bangsberg, ...
Journal of Antimicrobial Chemotherapy 58 (5), 1036-1043, 2006
672006
SPAR: stochastic programming with adversarial recourse
MD Bailey, SM Shechter, AJ Schaefer
Operations Research Letters 34 (3), 307-315, 2006
392006
Increasing the efficiency of Monte Carlo cohort simulations with variance reduction techniques
SM Shechter, AJ Schaefer, RS Braithwaite, MS Roberts
Medical Decision Making 26 (5), 550-553, 2006
382006
Estimating the rate of accumulating drug resistance mutations in the HIV genome
RS Braithwaite, S Shechter, CCH Chang, A Schaefer, MS Roberts
Value in Health 10 (3), 204-213, 2007
362007
Screening strategies for patients on the kidney transplant waiting list
A Sabouri, WT Huh, SM Shechter
Operations Research 65 (5), 1131-1146, 2017
192017
A modeling framework for replacing medical therapies
SM Shechter, MD Bailey, AJ Schaefer
IIE Transactions 40 (9), 861-869, 2008
182008
Patient-type Bayes-adaptive treatment plans
MR Skandari, SM Shechter
Operations research 69 (2), 574-598, 2021
162021
Optimal vascular access choice for patients on hemodialysis
MR Skandari, SM Shechter, N Zalunardo
Manufacturing & Service Operations Management 17 (4), 608-619, 2015
162015
Setting sites for faster results: Optimizing locations and capacities of new tuberculosis testing laboratories
F Saveh-Shemshaki, S Shechter, P Tang, J Isaac-Renton
IIE Transactions on Healthcare Systems Engineering 2 (4), 248-258, 2012
152012
Cost-effectiveness analysis of vascular access referral policies in CKD
SM Shechter, T Chandler, MR Skandari, N Zalunardo
American Journal of Kidney Diseases 70 (3), 368-376, 2017
142017
The system can't perform the operation now. Try again later.
Articles 1–20